Molecular and functional analysis of γδ T cell expansions in immunodeficient patients

  • Paul Fisch1,

    Affiliated with

    • Petros Christopoulos2,

      Affiliated with

      • Elisabeth Nikolopoulos1,

        Affiliated with

        • Hendrik Veelken2 and

          Affiliated with

          • Stephan Wehl3

            Affiliated with

            Diagnostic Pathology20072(Suppl 1):S8

            DOI: 10.1186/1746-1596-2-S1-S8

            Published: 14 March 2007

            Aims

            Patients with various forms of immunodeficiencies frequently show expansions of γδ T cells in their peripheral blood. We attempted to characterize the γδ T cell subpopulations in these patients and possibly elucidate the cellular mechanisms involved in the γδ T cell expansions in some of these patients.

            Methods and results

            Two adult patients with thymoma and γδ T cell expansions were studied by flow cytometry and T cell receptor γ- and δ-chain spectratyping. One patient suffering from leishmaniasis and thymic carcinoma showed a peculiar polyclonal γδ T cell proliferation while another patient with a benign thymoma and CMV reactivation had a persistent oligoclonal amplification of γδ T cells. In one pediatric patient with incomplete RAG-1 deficiency, we found a restricted variability of the expressed Vδ3, versus Vδ1 and Vδ2 chains and a seemingly monoclonal usage of the Vγ4 element. Sequencing revealed that these γδ T cells showed significant junctional diversity. These data suggested selection of the γδ T cells by antigens such as CMV infection. Indeed, 4 out of 5 δ T cell clones that could be derived from this patient secreted TNFα in response to CMV infected allogeneic fibroblasts.

            Conclusion

            Overall, studies of human γδ T cells under the conditions of a limited immune system imply two non-exclusive explanations for the γδ T cell predominance in immunodeficiencies: a) a developmental advantage of γδ T cells, possibly by a less stringent T cell development than for αβ T cells and b) a proliferative response caused by infectious or autoantigen-driven peripheral stimulations, such as CMV infections.

            Authors’ Affiliations

            (1)
            Institut für Pathologie, Universitätsklinikum Freiburg
            (2)
            Abteilung Hämatologie/Onkologie, Universitätsklinikum Freiburg
            (3)
            Zentrum für Kinderheilkunde und Jugendmedizin Universitätsklinikum Freiburg

            Copyright

            © Fisch et al 2007

            This article is published under license to BioMed Central Ltd.

            Advertisement